Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2, 1 NA. Research is primarily industry-sponsored.
6 publications have been identified in PubMed for baldness, male pattern. Research spans Basic Science / Preclinical (33%), Case Report / Case Series (17%), and Clinical Trial Publication (17%).
Pan L (2026). [PMID: 41752186](https://pubmed.ncbi.nlm.nih.gov/41752186/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Lakdawala FM (2025). [PMID: 40698504](https://pubmed.ncbi.nlm.nih.gov/40698504/). *JPMA. The Journal of the Pakistan Medical Association*. [Gene Therapy / Novel Therapeutics]
Li M (2025). [PMID: 40301276](https://pubmed.ncbi.nlm.nih.gov/40301276/). *Hormones (Athens, Greece)*. [Epidemiology / Natural History]
De La Torre S (2025). [PMID: 41048687](https://pubmed.ncbi.nlm.nih.gov/41048687/). *AACE endocrinology and diabetes*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
Li Y (2024). [PMID: 39350767](https://pubmed.ncbi.nlm.nih.gov/39350767/). *Frontiers in genetics*. [Basic Science / Preclinical]
AI-curated news mentioning baldness, male pattern
Updated Apr 27, 2026
Veradermics reports positive data for its oral treatment targeting male pattern baldness, potentially paving the way for the first new approval in decades. The therapy may face competition from existing generics and over-the-counter options.